Skip to main content

233 publications

Name Date Type Actions

Availability of the 2025 Universal Registration Document

On 29 April 2026, Vetoquinol filed its 2025 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format).

Public releases

Sales for 1st quarter 2026

Sales: €125 million -0.3% at constant exchange rates

Public releases

2025 Annual results

Annual sales: €526 m (+0.2% at constant exchange rates)
Essential Products sales: €334 m (+4.1% at constant exchange rates)
EBIT before amortization of acquired assets: €92 m (17.4% of sales)
Net result, Group share: €57 m (10.9% of sales)
Cash flow generation: €72 m

Public releases

Annual sales 2025: €526 million

Annual sales: €526 million (up 0.2% at constant exchange rates and down 2.5% on a reported basis)
Annual sales of Essential Products: €334 million (up 4.1% at constant exchange rates and up 2.1% on a reported basis)

Public releases

Avis de projet de fusion (french)

Avis de projet de fusion par voie d'absorption de la Vetoquinol Scandinavia AB par la société Vetoquinol S.A.

Public releases , Shareholders´s Meeting

Avis d'information (french)

Avis d'information des associes, des créanciers et des délégués du personnel ou à défaut des salaries eux-mêmes

Public releases , Shareholders´s Meeting

Sales at end september 2025

9-month sales: €384 million (-1.3% at constant exchange rates and -3.5% on a reported basis)
9-month sales of Essential products: €244 million (64% of sales, +2.7% at constant exchange rates and +1.1% on a reported basis)

Public releases

2025 Half-Year Results

Sales: €258m (-1.0% at constant exchange rates)
Essential products sales: €165m (+4.2% at constant exchange rates)
Net income, Group share: €25m (9.7% of sales)
EBITDA: €53m (20.4% of sales)
Cash flow generation: €51m

Public releases

Rapport financier semestriel 2025 (french)

Rapport financier semestriel 2025 (french)

Half Year Report

2025 Half-Year Results

Contents:
01. Activity for the first half of 2025
02. Consolidated results for the first half of 2025
03. Strategy and outlook

Half Year Report